An epithelial-mesenchymal transition-related 5-gene signature predicting the prognosis of hepatocellular carcinoma patients

被引:19
|
作者
Zhu, Gongmin [1 ,2 ]
Xia, Hongwei [1 ,2 ]
Tang, Qiulin [1 ,2 ]
Bi, Feng [1 ,2 ]
机构
[1] Sichuan Univ, West China Hosp, Canc Ctr, Dept Abdominal Oncol, 37 Guoxue Lane, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, Lab Mol Targeted Therapy Oncol, 37 Guoxue Lane, Chengdu 610041, Sichuan, Peoples R China
基金
中国国家自然科学基金;
关键词
Epithelial-mesenchymal transition; Hepatocellular carcinoma; Prognostic signature; PDCD6; TCGA;
D O I
10.1186/s12935-021-01864-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundTumor metastasis is one of the leading reasons of the dismal prognosis of hepatocellular carcinoma (HCC). Epithelial-mesenchymal transition (EMT) is closely associated with tumor metastasis including HCC. The purpose of this study is to construct and validate an EMT-related gene signature for predicting the prognosis of HCC patients.MethodsGene expression data of HCC patients was downloaded from The Cancer Genome Atlas (TCGA) database. Gene set enrichment analysis (GSEA) was performed to found the EMT-related gene sets which were obviously distinct between normal samples and paired HCC samples. Cox regression analysis was used to develop an EMT-related prognostic signature, and the performance of the signature was evaluated by Kaplan-Meier curves and time-dependent receiver operating characteristic (ROC) curves. A nomogram incorporating the independent predictors was established. Quantitative real-time polymerase chain reaction (qRT-PCR) was used to detect the expression levels of the hub genes in HCC cell lines, and the role of PDCD6 in the metastasis of HCC was determined by functional experiments.ResultsAn EMT-related 5-gene signature (PDCD6, TCOF1, TRIM28, EZH2 and FAM83D) was constructed using univariate and multivariate Cox regression analysis. Based on the signature, the HCC patients were classified into high- and low-risk groups, and patients in high-risk group had a poor prognosis. Time-dependent ROC and Cox regression analyses suggested that the signature could predict HCC prognosis exactly and independently. The predictive capacity of the signature was also validated in two external cohorts. GSEA results showed that many cancer-related signaling pathways such as PI3K/Akt/mTOR pathway and TGF-beta /SMAD pathway were enriched in high-risk group. The result of qRT-PCR revealed that PDCD6, TCOF1 and FAM83D were highly expressed in HCC cancer cells. Among them, PDCD6 were found to promote cell migration and invasion.ConclusionThe EMT-related 5-gene signature can serve as a promising prognostic biomarker for HCC patients and may provide a novel mechanism of HCC metastasis.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] An epithelial-mesenchymal transition-related 5-gene signature predicting the prognosis of hepatocellular carcinoma patients
    Gongmin Zhu
    Hongwei Xia
    Qiulin Tang
    Feng Bi
    Cancer Cell International, 21
  • [2] Development and validation of an epithelial-mesenchymal transition-related gene signature for predicting prognosis
    Zhou, De-Hua
    Du, Qian-Cheng
    Fu, Zheng
    Wang, Xin-Yu
    Zhou, Ling
    Wang, Jian
    Hu, Cheng-Kai
    Liu, Shun
    Li, Jun-Min
    Ma, Meng-Li
    Yu, Hua
    WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (26) : 9285 - 9302
  • [3] Identification of a Novel Epithelial-Mesenchymal Transition-Related Gene Signature for Endometrial Carcinoma Prognosis
    Ruan, Tianyuan
    Wan, Jing
    Song, Qian
    Chen, Peigen
    Li, Xiaomao
    GENES, 2022, 13 (02)
  • [4] Epithelial-mesenchymal transition-related gene prognostic index and phenotyping clusters for hepatocellular carcinoma patients
    Wang, Xiaojing
    Zeng, Wangyuan
    Yang, Lu
    Chang, Tanjie
    Zeng, Jiangzheng
    CANCER GENETICS, 2023, 274 : 41 - 50
  • [5] A novel epithelial-mesenchymal transition-related gene signature for prognosis prediction in patients with lung adenocarcinoma
    Feng, Shengyu
    Huang, Ce
    Guo, Liuling
    Wang, Hao
    Liu, Hailiang
    HELIYON, 2022, 8 (01)
  • [6] Identification of an Epithelial-Mesenchymal Transition-Related Long Non-coding RNA Prognostic Signature to Determine the Prognosis and Drug Treatment of Hepatocellular Carcinoma Patients
    Huang, Shenglan
    Li, Dan
    Zhuang, Lingling
    Zhang, Jian
    Wu, Jianbing
    FRONTIERS IN MEDICINE, 2022, 9
  • [7] A Novel Epithelial-Mesenchymal Transition Gene Signature Correlated With Prognosis, and Immune Infiltration in Hepatocellular Carcinoma
    Kong, Weihao
    Mao, Zhongxiang
    Han, Chen
    Ding, Zhenxing
    Yuan, Qianqian
    Zhang, Gaosong
    Li, Chong
    Wu, Xuesheng
    Chen, Jia
    Guo, Manyu
    Hong, Shaocheng
    Yu, Feng
    Liu, Rongqiang
    Wang, Xingyu
    Zhang, Jianlin
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [8] A novel epithelial-mesenchymal transition gene signature for the immune status and prognosis of hepatocellular carcinoma
    Shi, Yanlong
    Wang, Jingyan
    Huang, Guo
    Zhu, Jun
    Jian, Haokun
    Xia, Guozhi
    Wei, Qian
    Li, Yuanhai
    Yu, Hongzhu
    HEPATOLOGY INTERNATIONAL, 2022, 16 (04) : 906 - 917
  • [9] Identification of prognostic markers for hepatocellular carcinoma based on the epithelial-mesenchymal transition-related gene BIRC5
    Xu, Rongzhong
    Lin, Liubing
    Zhang, Bo
    Wang, Jian
    Zhao, Fanchen
    Liu, Xiaolin
    Li, Yiping
    Li, Yan
    BMC CANCER, 2021, 21 (01)
  • [10] Identification of prognostic markers for hepatocellular carcinoma based on the epithelial-mesenchymal transition-related gene BIRC5
    Rongzhong Xu
    Liubing Lin
    Bo Zhang
    Jian Wang
    Fanchen Zhao
    Xiaolin Liu
    Yiping Li
    Yan Li
    BMC Cancer, 21